These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7614815)

  • 21. Steroid 11 beta-hydroxylase deficiency and related disorders.
    White PC
    Endocrinol Metab Clin North Am; 2001 Mar; 30(1):61-79, vi. PubMed ID: 11344939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A de novo unequal cross-over mutation between CYP11B1 and CYP11B2 genes causes familial hyperaldosteronism type I.
    Carvajal CA; Stehr CB; González PA; Riquelme EM; Montero T; Santos MJ; Kalergis AM; Fardella CE
    J Endocrinol Invest; 2011 Feb; 34(2):140-4. PubMed ID: 20634641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial hyperaldosteronism.
    Stowasser M; Gordon RD
    J Steroid Biochem Mol Biol; 2001 Sep; 78(3):215-29. PubMed ID: 11595502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone-suppressible hyperaldosteronism: clinical, biochemical and genetic relations.
    Connell JM; Inglis GC; Fraser R; Jamieson A
    J Hum Hypertens; 1995 Jun; 9(6):505-9. PubMed ID: 7473536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.
    Carvajal CA; Campino C; Martinez-Aguayo A; Tichauer JE; Bancalari R; Valdivia C; Trejo P; Aglony M; Baudrand R; Lagos CF; Mellado C; Garcia H; Fardella CE
    Hypertension; 2012 Jan; 59(1):85-91. PubMed ID: 22083159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism.
    MacConnachie AA; Kelly KF; McNamara A; Loughlin S; Gates LJ; Inglis GC; Jamieson A; Connell JM; Haites NE
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4328-31. PubMed ID: 9851772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disorders of steroid 11 beta-hydroxylase isozymes.
    White PC; Curnow KM; Pascoe L
    Endocr Rev; 1994 Aug; 15(4):421-38. PubMed ID: 7988480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hybrid gene or hybrid steroids in the detection and screening for familial hyperaldosteronism type I.
    Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):444-6. PubMed ID: 8582097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation of phenotype in patients with glucocorticoid remediable aldosteronism.
    Gates LJ; MacConnachie AA; Lifton RP; Haites NE; Benjamin N
    J Med Genet; 1996 Jan; 33(1):25-28. PubMed ID: 8825044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered 11 beta-hydroxylase activity in glucocorticoid-suppressible hyperaldosteronism.
    Jamieson A; Ingram MC; Inglis GC; Davies E; Fraser R; Connell JM
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2298-302. PubMed ID: 8964867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.
    Kamrath C; Maser-Gluth C; Haag C; Schulze E
    Horm Res Paediatr; 2011; 76(2):93-8. PubMed ID: 21625068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticoid-remediable aldosteronism.
    Halperin F; Dluhy RG
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):333-41, viii. PubMed ID: 21565670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild-type genes.
    Stowasser M; Gartside MG; Taylor WL; Tunny TJ; Gordon RD
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3670-6. PubMed ID: 9360524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.
    Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyperaldosteronism suppressible by glucocorticoids. An unusual cause of familial hypertension].
    Pasquet A; Thibaut A; Maiter D; De Plaen JF
    Ann Endocrinol (Paris); 1995; 56(2):149-53. PubMed ID: 7755343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Family hyperaldosteronism type I: a clinical case and review of literature.
    Chikladze NM; Favorova OO; Chazova IE
    Ter Arkh; 2018 Sep; 90(9):115-122. PubMed ID: 30701745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism.
    Ding W; Liu L; Hu R; Xu M; Chen J
    Chin Med J (Engl); 2002 Jul; 115(7):979-82. PubMed ID: 12150724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension.
    Jonsson JR; Klemm SA; Tunny TJ; Stowasser M; Gordon RD
    Biochem Biophys Res Commun; 1995 Feb; 207(2):565-71. PubMed ID: 7864844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene.
    Torpy DJ; Gordon RD; Lin JP; Huggard PR; Taymans SE; Stowasser M; Chrousos GP; Stratakis CA
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3214-8. PubMed ID: 9745430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New genetic insights in familial hyperaldosteronism.
    Jackson RV; Lafferty A; Torpy DJ; Stratakis C
    Ann N Y Acad Sci; 2002 Sep; 970():77-88. PubMed ID: 12381543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.